In depth analysis of the HIV reservoir confirms effectiveness and safety of DTG/3TC in a phase 4 randomized controlled switch trial (RUMBA).
De Scheerder MA, Degroote S, Delporte M, Kiselinova M, Trypsteen W, Vincke L, De Smet E, Van Den Eeckhout B, Schrooyen L, Verschoore M, Muccini C, Vanherrewege S, Caluwe E, De Buyser S, Gerlo S, Blomme E, Vandekerckhove L.
De Scheerder MA, et al. Among authors: delporte m.
J Infect Dis. 2024 Sep 3:jiae405. doi: 10.1093/infdis/jiae405. Online ahead of print.
J Infect Dis. 2024.
PMID: 39226296